Winter dealmaking signals another consolidation push in pet care
A fresh round of winter dealmaking is underscoring how quickly the pet industry continues to consolidate across categories. GlobalPETS reported a new wave of M&A activity in early 2026, and the pattern stretches from premium pet food to digital care platforms and veterinary-adjacent services. Among the clearest recent examples is AlphaPet Ventures’ March 27 acquisition of Cpro Food, a Belgian super-premium dog and cat food brand, as well as the continued expansion of Rover and portfolio reshaping at Covetrus. (globalpetindustry.com)
The backdrop is a pet market that has cooled from its pandemic-era frenzy but remains structurally attractive to investors. Deal advisers and market analysts say 2024 was slower in some pet segments, but private equity and strategic buyers kept pursuing add-ons, especially where they could gain scale, geography, or recurring revenue. Capstone Partners said clarity on 2026 performance and continued consolidation opportunities in services could support a stronger M&A environment, while IMAP pointed to a healthy pipeline for both private equity and strategic acquirers. S&P Global previously reported that announced investment in pet care, food, and supplies jumped sharply in 2023, showing that investor appetite never really disappeared. (capstonepartners.com)
AlphaPet’s latest move fits that playbook neatly. In its announcement, the Munich-based company said Cpro Food becomes its fifth acquisition since 2020. AlphaPet described Cpro as a leading super-premium Belgian brand founded in 2014 by sisters Anne-France and Béatrice Germeau, with dry food, wet food, and treats distributed through specialty retailers and breeders. The company said the deal strengthens its “local hero” portfolio and opens a Belgian market it characterized as having one of Europe’s highest premium shares. AlphaPet has been explicit with investors that future growth is expected to come from both organic expansion and further buy-and-build across Europe. (webdisclosure.com)
Rover offers a parallel example on the services side. Blackstone completed its $2.3 billion acquisition of Rover on February 27, 2024, taking the pet-care marketplace private while leaving the brand in place. Since then, Rover has used M&A to deepen its European reach. In April 2025, the company announced the acquisition of Gudog, adding a network of 20,000 dog sitters and walkers across several European markets and building on its October 2024 acquisition of Cat in a Flat. That sequence suggests a familiar private-equity pattern: acquire a scaled platform, then use tuck-in deals to accelerate geographic expansion and category depth. That last point is an inference based on the timing and structure of the transactions. (blackstone.com)
Covetrus illustrates a different M&A use case: portfolio focus. In October 2025, Covetrus announced an agreement to sell SmartEquine to Chewy, saying the transaction would help it sharpen its focus on its core business of technology-enabled solutions for veterinarians. Chewy framed the same deal as a way to strengthen its position in equine health and expand into higher-margin wellness categories. For veterinary professionals, that’s a notable signal that animal-health companies are still actively deciding which lines best fit their long-term strategy, and which assets are more valuable in someone else’s hands. (prnewswire.com)
Industry commentary points to a market that is active, but more selective than it was a few years ago. Lincoln International said investors continue to see opportunity across animal health products and services, while IMAP said services deal flow held up better than some other pet segments. At the same time, broader reporting has shown growing public scrutiny of private equity’s role in veterinary care, especially around affordability and consolidation. That tension matters because it means future deals may be judged not only on growth logic, but also on how they affect pricing, access, and trust for clinics and pet parents. (lincolninternational.com)
Why it matters: For veterinary professionals, winter’s deal activity is less about any single transaction than the direction of travel. Consolidation is spreading across the ecosystem around clinical care: nutrition brands, e-commerce, care marketplaces, and practice-support technology. That can bring better scale and integration, but it can also shift referral patterns, purchasing options, client expectations, and competitive pressure. Practices may increasingly find themselves working alongside larger, better-capitalized partners, while pet parents encounter more vertically integrated companies promising food, services, products, and care through a single brand relationship. (prnewswire.com)
What to watch: The next key question is whether 2026 produces more bolt-on deals like AlphaPet’s and Rover’s, or larger platform transactions involving veterinary distribution, software, and services. Analysts broadly expect consolidation to continue where markets remain fragmented and where buyers can show a clearer path to integration, margin improvement, or cross-border growth. For veterinary teams, that makes it worth watching not just who gets acquired, but how quickly those new parent companies change strategy, pricing, channel mix, and partner relationships. (imap.com)